BofA Securities said it expects the December quarter for Voltas to remain subdued due to seasonality, but believes the weakness is largely priced in.
Rupee traded narrowly against US dollar, supported by RBI intervention amid India–US trade uncertainty. Brent crude rose, Sensex and Nifty fell, FIIs remained net buyers,…
Meesho shares listed on the stock exchanges on December 10 at a 46% premium and closed 53% above its issue price. Its three-day IPO of…
Sun Pharma said it continues to manufacture and supply approved products from the facility to the US market.
Arvind Sanger, Managing Partner, Geosphere Capital Management expressed hope that 2026 will mark a phase of earnings acceleration for Indian companies.
In an interaction with CNBC-TV18 on Thursday, December 18, Tawakley explained his rationale behind avoiding the space, that has been a wealth creator, barring the…
Sandeep Parekh, Managing Partner at Finsec Law Advisors, believes the new brokerage cap will negatively affect the quality of institutional research available to funds and…
Last week, the US drug regulator had issued another Form 483 with three observations to Aurobindo Pharma after inspecting its Unit-V, an active pharmaceutical ingredient…
JPMorgan is positive on the Tata Motors CV stock due to expectations of a modest recovery in the CV cycle after three years of no…
While Jefferies remains constructive on the overall two wheeler demand outlook, it said that the GST cut driven demand boost has faded during November and…